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Abstract: Objective: Spinal chordomas are rare, locally invasive, malignant neoplasm, 
representing 5% of all malignant tumors of the skeleton. In the majority of cases the 
segment involved is the sacrum. This study reviews our experience during the last 15 
years at The Spinal Surgery Department of “Bagdasar-Arseni” Clinical Hospital, to 
determine the effects of various treatment methods on the overall course of this disease 
process. Methods: A retrospective study was performed, from 2000 to 2015, in which, 31 
patients with spinal chordomas were evaluated at our institution. Results: Two thirds of 
patients were male, with a mean age of 57 years. Patients presented with local pain, 
radiculopathy and bladder-bowel dysfunction at hospital admission. There were 24 
patients with sacral chordomas, 4 with cervical chordomas, 2 with thoracic and one with 
lumbar chordoma. All patients underwent at least one surgical procedure. The main goal 
of surgery was to achieve total resection of the tumor. Conclusion: Our study suggests 
that spinal chordomas are rare tumors with a high risk of tumor recurrence. If total 
resection is achieved, the risk of recurrence diminishes. If the tumor resection is subtotal, 
than recurrence appears in all cases. After tumor resection, the surgeon faces the problem 
of spinal instability that needs solving. Based on these findings, we think that, whenever 
possible, radical resection should be the treatment of choice for spinal chordomas. 
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Introduction 
Chordomas are rare tumors, representing 
almost 5% af all malignant spinal tumors of the 
skeleton. They are regarded as slow growing 
tumors originated from the notochord which 
is implicated in the development of the axial 
skeleton. The superior portion of the 
notochord approaches the future sphenoid 
bone and develops into the occipital bone and 
the inferior portions develops into the sacrum 
and the coccyx. So chordomas can be located 
all the way from the spheno-occipital region to 
  
 
 
 
16          Calina et al          Chordomas: a 15-year experience 
 
 
 
 
 
 
 
the sacrococcygeal region. The main affected 
segment is the sacrum, followed by the 
spheno-occipital region and only in rare cases 
the mobile spine. (1) 
Despite their slow growth treating spinal 
chordomas remains a challenge for 
neurosurgeons as tumor recurrence is very 
often. Radiation therapy has been used for the 
treatment of spinal chordomas in association 
with surgical treatment. (2, 3, 4) 
Patients that present with sacrococcygeal 
chordomas are in the majority of cases 
between 50 an 70 years old, and, usually, 
patients with tumors located in the spheno-
occipital region are one decade younger. The 
reason for this is probably less space for 
spheno-occipital chordomas before causing 
clinical symptoms. (5) 
Metastases are mainly located in the lungs, 
liver and lymph nodes and occur in 3-48% of 
patients. (8-10)  
Local recurrence is the main problem in 
spinal chordomas and the main adverse 
prognostic factor. They are often insensitive to 
chemotherapy and radiotherapy.  
Epidemiological data 
Chordomas are malignant tumors with a 
very aggressive local invasion. The incidence is 
0.08 per 100.000 people and make up for 
almost 5% of all malignant primary tumors of 
the skeleton. (6) The main category affected by 
this disease is represented by people above 50 
years. The presence of chordomas is very rare 
in people younger than 40 years. The median 
survival period is 6.29 years with a 10 year 
survival of 39.9% (7).  
We included 31 patients with spinal 
chordomas, that were treated between 2000 
and 2014 with a mean age of 57 years old. The 
youngest patient treated was 6 years old and 
the oldest patient was 81 years old. We 
observed that 80% of patients were older than 
50 years and also noted  a male predominance, 
the sex ratio male / female being 2/1 . 67.7% of 
patients were male and 32.3% female. 
 
 
Figure 1 - Sex distribution in patients with spinal 
chordomas 
 
The study did not include patients with 
chordomas of the spheno-occipital region, 
only patients with spinal chordomas being 
admitted. In the majority of cases, 24 patients, 
the tumor was located in the sacral segment of 
the spine. There were 7 patients with 
chordomas of the mobile spine, 4 in the 
cervical region, 2 in the thoracic region and 1 
in the lumbar region of the spine. Although we 
observed a higher prevalence for the thoracic 
spine the limited number of patients did not 
allow us to determine the most frequent 
vertebral level affected in the mobile spine.  
In the majority of cases with sacral 
chordomas, 21 cases, the tumor involved only 
the inferior part of the sacrum. We observed a 
very low percentage of tumors located at the 
sacro-lumbar junction. 
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Figure 2 - Most frequent location of spinal 
chordomas 
 
 
Figure 3 - Most frequent location of mobile spine 
chordomas 
 
 
Figure 4 - Admission symptoms of patients with 
spinal chordomas 
Patients and methods 
The article represents a retrospective study 
that includes all patients with spinal 
chordomas treated in our department in the 
last 15 years. There were 31 patients included, 
21 male and 10 female.  
 The majority of patients admitted 
presented for local pain and only in rare cases, 
patients presented for radiculopathy or 
bladder and bowel dysfunctions. Local pain 
was present in 28 cases, radiculopathy in 4 
cases, bladder or bowel dysfunctions in 4 cases 
and mielopathy in only one case.  
In evolution, the first symptom that 
occurred was local pain, which, if left 
untreated, lead to radiculopathy and in late 
stages to bladder and bowel dysfunctions. The 
mean duration of symptoms was 16 months, 
12 months for men and 20 months for female. 
Symptoms presented a slow progression from 
initial appearance to the moment of surgery.  
Clinical symptoms are not specific for these 
lesions and progression is slow causing late 
hospital presentation and late diagnosis, in 
advanced stages with large tumor extension.  
Diagnostic procedures 
The first diagnostic procedure is 
represented by plain x-ray demonstrating a 
lytic lesion or osteosclerosis in rare cases. (12, 
13, 14, 15, 16, 17) The most frequent 
radiological finding is considered to be 
destruction of spine segments with soft-tissue 
extension. Chordomas localized in the mobile 
spine originate in a single vertebral body 
usually. The intervertebral discs are spared by 
tumor extension. (18, 19, 20) 
  
 
 
 
18          Calina et al          Chordomas: a 15-year experience 
 
 
 
 
 
 
 
Computerized tomography scanning is 
very important in establishing the grade of 
tumor extent. (12) The main tumor extension 
is usually anterior to the vertebral body 
displacing the major vessels or the ureters 
depending on the vertebral segment implied. 
CT scan is very useful for demonstrating the 
full extent of the tumor. (21) 
Chordomas present low-intensity signal on 
T1- weighted MRI and high-intensity signal 
on T2- weighted MRI. MRI offers the best 
possibility of diagnosis in spinal chordomas 
being very valuable in preoperative 
assessment, accurately depicting the tumor 
extent. (22, 23, 24, 25, 26, 27, 28) 
In our study we observed the presence of 
osteolytic processes in 100% of cases, being the 
major imagistic characteristic for spinal 
chordomas. We also observed the presence of 
soft tissue extension in 93% of cases. There 
were also 6% of cases that presented 
intratumoral calcifications. Another imagistic 
characteristic observed in the study was 
reduced uptake on bone scintigraphy. 
 
TABLE 1 
Imagistic characteristics 
IMAGISTIC CHARACTERISTICS OF SPINAL 
CHORDOMA 
 
Osteolytic process 100% 
Soft tissue extension 93% 
Intratumoral calcifications 6% 
Treatment 
There are two main types of treatment for 
spinal chordomas, surgical treatment and 
radiotherapy. Surgery is the treatment of 
choice, offering the best an only change of 
cure. (29, 30, 31) 
Surgical treatment  
The main goal of surgical treatment is 
complete tumor resection, spinal 
decompression (if needed), and, after tumor 
resection, spinal reconstruction. Any surgical 
procedure without complete tumor resection 
will lead to tumor recurrence, usually with a 
more aggressive behavior and with a very low 
chance of complete resection leading 
inevitable to death. (23, 32) 
Complete tumor resection should be done 
with wide resection margins. Often, wide 
excision is difficult to achieve, but, the surgeon 
should have in mind that complete tumor 
resection is the only hope of total cure. In 
order to achieve complete resection careful 
preoperative case assessment is imperative. 
(23, 32, 33, 34, 24, 35) 
Surgical treatment was applied in all cases 
the main goal being complete tumor resection 
and spinal decompression without neurologic 
impairment for the patient. We managed to 
achieve complete macroscopic tumor 
resection in 77% percent of cases and 
incomplete tumor resection in 33% of cases. 
None of the patients included in the study 
underwent spinal biopsies.  
The main factor that influenced tumor 
resection was the vertebral level implied. Out 
of the 24 patients with sacral chordoma, 
complete tumor resection was achieved in 21 
cases. There were 4 patients with cervical 
chordoma, 2 with complete tumor resection 
and 2 with incomplete resection, 2 patients 
with thoracic chordoma, both with incomplete 
tumor resection and one patient with lumbar 
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chordoma with incomplete tumor resection. 
The type of resection was evaluated 
macroscopic and under magnification. 
 
TABLE 2 
Resection type depending on tumor location 
REGION COMPLETE 
RESECTION 
INCOMPLETE 
RESECTION 
CERVICAL 2 2 
THORACIC 0 2 
LUMBAR 0 1 
SACRAL 21 3 
 
A throw preoperative evaluation of each 
case is needed, each case being particular. We 
used a multidisciplinary team approach in 8 
cases associating a thoraco-abdominal 
surgeon and sometimes even a plastic surgeon.  
Only 5 cases out of the 31 patients required 
spinal reconstruction using autologus bone 
grafts, screws, rods, and intervertebral 
implants. The reduced number of cases with 
spinal reconstruction is justified by the large 
number of tumors located in the inferior part 
of the sacrum where there is no need for spinal 
reconstruction. In all of the cases with spinal 
reconstruction the tumor was located in the 
mobile spine, 4 in the cervical spine and one in 
the thoracic spine.  Complete tumor resection 
was achieved in 2 out of this 5 cases.  
Surgical treatment in sacral chordoma 
The sacrum represents the main location 
for sacral chordomas. 77% of patients (24 
cases) presented sacral chordomas. Surgical 
treatment was applied in all cases. In 21 cases 
we have chosen a posterior approach and, in 3 
cases, a combined approach. We managed to 
achieve complete tumor resection in 21 cases 
and incomplete resection in 3 cases. In these 3 
cases patients presented in a very late stage of 
tumor evolution with large tissue invasion. In 
these cases the tumor presented anterior 
extension surpassing the retrorectal fat tissue 
invading the rectum. A mixed operatory team 
was necessary and a combined approach, 
anterior and posterior was used. All 3 cases 
required rectal excision and colostomy. 
Despite extensive surgical interventions, 
complete tumor resection was not possible. 
 
 
Figure 5 - Number of surgical procedures per patient 
with sacral chordoma 
 
In 17 cases with sacral chordoma, only one 
surgical procedure was needed. It should be 
noted that the best chance of achieving 
complete tumor resection is in the first 
surgical procedure. Reintervention for tumor 
recurrence has a higher degree of difficulty and 
the chances of complete resection are slim. 5 
patients required 2 surgical procedures and 
one patient required three surgical procedures.  
As we reminded earlier, complete tumor 
resection is the main objective in treating 
chordomas. We observed that the tumor 
recurrence rate in patients with incomplete 
tumor resection was 100%, and only 14% in 
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patients with complete macroscopic tumor 
resection. The disease free interval was also 
very different between the 2 groups, 27 months 
in patients with complete resection opposed to 
only 8 months in patients with incomplete 
tumor resection. Although we classified it as 
complete tumor resection after macroscopic 
and magnification evaluation, 14% of patients 
presented tumor recurrence. 
 
 
Figure 6 - Disease free interval in patients with sacral 
chordoma 
 
Another challenge for the surgeon is the 
embedding of sacral nerve roots in the tumor 
mass. In the majority of cases the sacral nerves 
were embedded in the tumor or very adherent 
to the tumor mass.  In 87% of cases at least one 
sacral nerve had to be sacrificed. From 24 
patients with sacral chordoma, 4 patients 
presented tumors with large extend, involving 
bilateral sacral nerves. All 4 patients presented 
with bladder and bowel dysfunction from 
admission.  Aggressive tumor resection 
required sacral nerve sacrifice because 
dissection and decompression were not 
possible. The tumor embedded the sacral 
nerves from S1 to S5. Patients remained with 
permanent urinary catheter after surgical 
procedure.  
In 17 cases the sacrifice was limited to 1 or 
two nerves, unilateral and below S2 sacral 
nerve. We observed that preserving at least one 
S2 sacral nerve preserved the patient bladder 
function.  
As a general rule, if sacral nerve resection is 
needed in order to achieve total tumor 
resection, sacral nerves can be sacrificed safely, 
unilateral or bilateral, by preserving S1 and S2 
sacral nerve roots. In cases with tumors that 
involved S1 and S2 nerves, preserving these 
nerves was impossible in order to achieve large 
tumor resection. 
Postoperative complications were mainly 
represented by bladder and bowel 
dysfunctions. Although it was included in the 
preoperative planning and not considered a 
complication, it should be noted that rectal 
resection and permanent colostomy was 
needed in 3 cases.  
29% of patient presented bowel 
dysfunction after the surgical procedure which 
varies from minor emptying difficulties to 
incontinence. We observer that preserving S2 
and S3 sacral nerve roots preserves bowel 
function and, sacrificing S3 nerve roots causes 
a large array of bowel dysfunctions. 
50% of patients presented bladder 
dysfunction after surgical procedure, 33% 
without the need for a urinary catheter and 
17% requiring permanent urinary catheter. 
Patients with intact S2 sacral nerves presented 
minor or no bladder dysfunctions. 
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Figure 7 - Postoperative complications in patients 
with sacral chordoma 
 
We could not establish a standard 
approach for the treatment of spinal 
chordomas. Each case requires preoperative 
planning and cautious evaluation in order to 
achieve the maximal resection possible. The 
approach was influenced by tumor location, 
tumor size and adjacent tissue extension. 
Tumors that involve the S1 segment of the 
sacrum with downwards extension required 
complete sacrectomy, raising the problem of 
sacro-pelvic reconstruction.  
The indications for sacral reconstruction 
were: sacral resection above S2 vertebra, total 
sacral resection in which the whole sacroiliac 
joint is removed or partial sacral resection 
involving more than 50% of sacroiliac joint on 
each side.  
The surgical procedure is very complex, 
requiring the participation of specialists from 
several areas including neurosurgery, general 
surgery and plastic surgery. 
A variety of instrumentations has been 
used previously for reconstruction after total 
sacrectomy. From a biomechanical standpoint 
these devices progress in their level of 
sophistication as follows: the use of sacral bars 
spanning the ilia and connected to the spine 
with Harrington rods and hooks (8), the use of 
the more advanced Cotrel–Dubousset rods 
and hooks with the sacral bars (or AO plates) 
(37, 38), the use of transpedicular screws (and 
an internal spinal fixator) with iliac screws 
connected by plates (39) and the use of vertical 
Galveston rods attached to cross connecting 
spinal rods, plus a threaded transiliac rod.  
Reviewing the literature, a variety of 
techniques for sacro-pelvic reconstruction are 
described: sacro-iliac joint screw fixation, 
iliac-sacral screw fixation, posterior ilio-sacral 
plating and screw fixation, custom-made 
prosthesis, Galveston rod fixation with Iliac 
screws and trans-iliac rods. 
In the majority of cases, 21 patients, we 
used a posterior approach. A combined 
approach was used in only 3 cases. A posterior 
approach is suitable for the majority of 
patients with sacral chordomas because it 
provides good visibility of the sacral nerves 
and the rectum, allows good visibility and 
resection of paravertebral tissue invasion 
which in believed to be involved in tumor 
recurrence and it facilitates a complete 
resection using the retrorectal fat tissue as 
cleavage plan. It is also a more common 
approach because of the   familiarity with 
sacral anatomy for neurosurgeons. 
The approach strategy needs to be 
cautiously evaluated before the surgery. Al 21 
patients operated through a posterior 
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approach alone presented with sacral 
chordomas that didn’t extend beyond the 
retrorectal fat tissue invading the rectum. Al 3 
cases with rectal invasion were operated using 
a mixed operatory team through a combined 
approach, anterior and posterior. All cases 
associated rectal resection and permanent 
colostomy. As a general rule, posterior 
approach alone is not recommended in 
patients with sacral chordomas with rectal 
invasion.  
Surgical treatment in cervical chordoma 
In the studied interval 4 patients with 
cervical chordomas where admitted in our 
department. The vertebral levels affected were 
C5 in one case, C5 and C6 in one case, C3 and 
C4 in one case and C4, C5, C6 in one case.. 
Surgical treatment was applied in all cases, 
with spinal cord decompression, tumor 
resection and reconstruction. En block 
resection was not possible, piecemeal tumor 
resection being used in all cases.  
Anterior approach was used in 2 cases and 
a combined, anterior and posterior approach 
in the other 2 cases. All 4 cases required 
anterior reconstruction using bone graft 
fusion harvested from the iliac crest or from 
the fibula associated with anterior metallic 
fusion. Patients that were treated through a 
combined approach benefited also from 
posterior fusion using transarticular screws 
and rods.  
Total tumor resection was achieved in 2 
cases using a combined approach. In the other 
2 cases treated through an anterior approach 
only incomplete tumor resection was possible 
associated with spinal cord decompression. In 
one case, the tumor invaded the cervical nerves 
from C4 to C6, and in the other case both 
vertebral arteries were involved in the tumor 
mass. The tumor was very adherent to the 
adjacent tissues and we could not find a 
cleavage plan to separate these structures from 
the tumor mass. As complete tumor resection 
was never an option in these cases only 
palliative surgery was used with spinal cord 
decompression and anterior spinal 
reconstruction without a secondary posterior 
approach.  
The only complication observed was 
transitory dysphonia in 2 cases.  
Radiotherapy for spinal chordomas 
Radiotherapy was recommended in all 
cases treated in our department.  The value of 
radiotherapy in chordomas is long debated. 
Radiation doses of 30 to 50 Gy are indicated as 
palliative treatment with minimal risks. There 
are studies that report no difference in 
survival, duration of symptoms and 
progression in a heterogeneous group of 
patients that underwent radiotherapy with 50 
to 60 Gy compared with conventional 
fractions of less than 50 Gy. (40) Higher doses 
of 60 to 70 Gy are required for potentially 
curative intent. (41) To achieve this high doses 
the technique implies the association of 
conventional radiotherapy and proton-beam 
irradiation. Although the biological properties 
of proton beam are not significantly different 
from x-ray beams, their physical 
characteristics exhibited by a finite range of 
energy deposition with only minimal exit dose 
beyond the target region are significantly 
advantageous. These advantages are 
particularly important in achieving high-dose 
delivery to sacral chordomas. Using this 
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approach of x-ray and proton beam therapy 
combined with optimal surgery, improved 
local control was achieved at doses greater 
than 77 CGE. (42) 
All patients admitted in the study were 
treated after surgery with conventional 
radiotherapy. Unfortunately, proton beam 
therapy was not available. The results were 
disappointing. Although treated with 
radiotherapy patients developed tumor 
recurrence in all cases with incomplete 
resection and in 14% of cases with radical 
tumor resection. 
Case presentation 
A 65 year old woman  presents to  our 
department for local pain localized in the 
thoraco-lumbar junction, and neurologic 
deficit, graded Frankel D below T11, and 
radicular pain in T12 and L1 dermatomes on 
the right side. Plain X-RAYS were not helpful 
for diagnosis. After spinal MRI, we revealed a 
tumor with extension into the spinal canal, 
very adherent to the dura mater and severe 
cord compression with massive paravertebral 
extension and anterior extension to the limit of 
the retroperitoneal space, coming in close 
contact with the right kidney without invading 
it. . We used a posterior approach through L1 
complete laminectomy and partial T12, L2 
laminecomty. Almost all structures of L1 
vertebra were destroyed by the tumor mass. 
An L1 corpectomy was necessary with T12 and 
L1 discectomy. For spinal reconstruction we 
used an expandable cage, PMMA and 
posterior metallic fusion with transpedicular 
T12 and L2 screws.  
We managed to achieve complete tumor 
resection under optic magnification. The 
pacient was released from the hospital without 
with minimal neurologic deficit, and was 
without neurologic deficit at the 2 months 
follow-up. 
 
 
 
 
   Figure 8 - Initial MRI image of L1 spinal chordoma 
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After 1 year, she presented with Frankel D 
paraplegia, and radicular pain in L1 and L2 
dermatomes on the left side. Spinal MRI shows 
tumor recurrence situated on the left side with 
spinal cord compression. A second surgical 
procedure was necessary focused on the left 
side this time with disection and in-block 
resection of the tumor mass. The intersomatic 
cage was left in place and we used 
reconstruction with PMMA also in T12 and L2 
for better stability. Complete tumor resection 
under optic magnification was achieved. The 
patient was released with no neurologic deficit 
and no symptoms of spinal instability. At the 5 
year follow-up patient presented without 
tumor recurrence. 
 
   
Figure 9 - MRI image showing tumor recurrence after 1 year and postoperative control image after second 
surgical intervention 
 
Prognosis factors  
Because of the low incidence, only 0.5 cases 
per million people, there are few centers with 
large experience in treating this type of 
tumors, the majority of studies presenting very 
small series of patients or case presentations. 
(43, 44) 
The majority of earlier studies reported a 
very high rate of local recurrence and 
metastasis in up to 60% of sacral chordomas. 
(10, 24) The reported rates of local recurrence 
and metastasis depend on the quality of the 
initial surgery, the length of follow-up, and the 
autopsy rate. (44, 45) 
Tumor control in spinal chordomas 
improved significantly with more aggressive 
surgery. Local recurrence was almost a rule in 
the past, but, in our last 15 years we observed a 
tumor recurrence rate of 32%. Based on the 
type of tumor resection, the recurrence rate 
was 14% in cases considered with complete 
tumor resection and 100% in cases with 
incomplete tumor resection.  
The resection margins appear to be a 
critical factor in the final outcome of patients.  
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Based on our study we concluded that the 
main adverse prognosis factors in the 
treatment of spinal chordomas are:  
• Incomplete resection of the tumor 
with inadequate surgical margins 
• Large tumor size 
• Surgical procedures for tumor 
recurrence 
• Presence of metastases 
• Presence of microscopic tumor 
necrosis 
We noted some differences observed in 15 
years of treating spinal chordomas. The 
incidence increased over time, which we 
believe is mainly associated with an increased 
accessibility for CT and MRI imaging over the 
years. We also observed that postoperative 
neurologic impairment after surgery 
decreased in time. Although the percentage of 
patients with total tumor resection increased, 
the surgical procedures that were used were 
less invasive over time. Another thing that 
benefits complete tumor resection even if that 
means complete corpectomy or vertebrectomy 
is the evolution of spinal implants, restoring 
stability after complete tumor resection being 
no longer a problem.  
Conclusions 
Chordomas are rare tumors, affecting 
mainly the sacral segment of the spine. 
Patients present with unspecific clinical 
symptoms causing late hospital presentation 
and late diagnosis. The biggest concern is 
represented by tumor recurrence and local 
invasion if gross total resection is not achieved. 
The treatment of chordomas requires both 
aggressive resection and caution in achieving 
marginal tumor resection. If total resection is 
not achieved, tumor recurrence is a rule. 
Extensive tumor resection above S2 vertebra 
raises the problem of sacral reconstruction. 
From a histopathological point of view, 
chordomas are considered benign tumors, but, 
thanks to their aggressive recurrence they are 
classified as malignant tumors. Metastasis are 
rare but can occur, mainly in the lungs, liver 
and lymph nodes. Adjuvant therapy is 
controversial but known to contribute to long-
term disease control and survival. 
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